This cross-over trial involving 6 Blue Belgian double-muscled calves a
imed to investigate whether ipratropium bromide inhaled alone or in co
mbination with clenbuterol hydrochloride could prevent the dramatic cl
inical and pulmonary disturbances that are observed during an experime
ntally induced bronchoconstriction. Inhaled bronchodilators significan
tly influenced the clinical and functional responses of bovines subjec
ted to a 5-hydroxytryptamine perfusion. However, despite a mean (stand
ard error) wash-out period of 11.2 (3.1) and 7.5 (0.9) d after the 1st
and the 2nd one-day challenges, respectively, first-order carry-over
effects (ie those remaining from the previous treatment), effects of t
he period during which the treatment was allocated and interaction eff
ects did not allow a definitive interpretation of overall treatment di
fferences.